{
    "clinical_study": {
        "@rank": "51875", 
        "arm_group": {
            "arm_group_label": "Cardiovascular risk"
        }, 
        "biospec_descr": {
            "textblock": "CV biomarkers - inflammatory, metabolic, hypercoagulable and platelet."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "This is a non-randomized, non-interventional pilot observational study designed to follow\n      high-risk patients through their surgical and hospital stay.  The investigators will collect\n      2 4ml vial's of blood (total of 8ml) prior to surgery to assess CV biomarkers -\n      inflammatory, metabolic, hypercoagulable and platelet."
        }, 
        "brief_title": "Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients", 
        "completion_date": {
            "#text": "January 2020", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Coronary Artery Disease", 
            "Cerebral Vascular Disease", 
            "Peripheral Artery Disease", 
            "Renal Insufficiency", 
            "Diabetes", 
            "COPD", 
            "Hypertension", 
            "Active Smoker", 
            "Cancer", 
            "CHF", 
            "Prior DVT/PE"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Hypertension", 
                "Renal Insufficiency", 
                "Vascular Diseases", 
                "Peripheral Arterial Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is primarily an observational pilot study.  After identifying patients as\n      high-risk according to the following criteria: CAD and/or CVD and/or PAD and/or  >=60 years\n      old and at least 2 of the following - renal insufficiency, diabetes, COPD, hypertension,\n      active smoker (or active within 6 months of consent), cancer, congestive heart failure, or\n      any blood clot - they will be asked to sign a consent form.  Patients surgical and hospital\n      course will continue as per standard of care.  Prior to surgery, 8ml of blood will be\n      collected for to assess cardiovascular biomarkers including inflammatory, metabolic,\n      hypercoagulable and platelet biomarkers to be tested independently in Dr. Berger's lab in\n      Smilow.  Study staff will perform electrocardiograms on POD 2.  Results of these ECGs will\n      not be placed in the patients' charts.  No other procedures will be done for research\n      purposes only."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2022 \u2265 21 years of age\n\n               -  Subjects undergoing open orthopedic surgery of the hip, knee or spine\n\n               -  High-risk subject cohort:\n\n               -  Coronary artery disease (CAD), or\n\n               -  Cerebrovascular disease (CVD) (prior stroke, TIA or carotid artery disease (>70%\n                  stenosis), or\n\n               -  Peripheral artery disease (PAD), or\n\n               -  Age \u2265 60 years and any 2 of the following:\n\n                    -  Renal insufficiency (creatinine clearance < 60ml/min)\n\n                    -  Diabetes\n\n                    -  Chronic Obstructive Pulmonary Disease (COPD)\n\n                    -  Hypertension\n\n                    -  Active smoker or stopped less than 30 days prior to consent\n\n                    -  Cancer\n\n                    -  Congestive heart failure\n\n                    -  Prior blood clot\n\n        Exclusion Criteria:\n\n          -  \u2022 Severe co-morbid condition with life expectancy < 6 months\n\n               -  Inability to give informed consent or adhere to follow-up as per protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "This pilot, observational study is designed to identify and follow orthopedic surgical\n        patients meeting specific high-risk criteria for postoperative cardiovascular events.  All\n        normal standard of care will be maintained.  Patients will be observed from Pre-Admission\n        Testing (PAT) visit through hospital discharge."
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01809730", 
            "org_study_id": "S12-02513"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 12, 2013", 
        "location": {
            "contact": {
                "email": "germaine.cuff@nyumc.org", 
                "last_name": "Germaine Cuff, BSN, MPH, PHD", 
                "phone": "212-598-6074"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10003"
                }, 
                "name": "NYU Hospital for Joint Diseases"
            }, 
            "investigator": {
                "last_name": "Germaine Cuff, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Cardiac ischemia/necrosis", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Venous thromboembolism", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Pulmonary embolism", 
                "safety_issue": "No", 
                "time_frame": "30 dyas"
            }, 
            {
                "measure": "Myocardial infarction", 
                "safety_issue": "No", 
                "time_frame": "30 Days"
            }, 
            {
                "measure": "Cerebral vascular event", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Death", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Transient ischemic attack", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Surgical site infection", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Delayed wound healing", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Clinically relevant bleeding", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Transfusion within 48 hours post-op", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01809730"
        }, 
        "responsible_party": {
            "investigator_affiliation": "New York University School of Medicine", 
            "investigator_full_name": "Germaine Cuff", 
            "investigator_title": "Program Director, Research", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "New York University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "New York University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}